TGA Approval

APOTEX-RISEDRONATE/Ca 35/1250 risedronate sodium 35 mg tablet and calcium carbonate 1250 mg tablet composite blister pack (184626)

ARTG ID

184626

ARTG Name

APOTEX-RISEDRONATE/Ca 35/1250 risedronate sodium 35 mg tablet and calcium carbonate 1250 mg tablet composite blister pack

Sponsor

Arrotex Pharmaceuticals Pty Ltd

ARTG Date

April 13, 2012

Registration Type

Medicine

Therapeutic Good Type

Medicine

Licence Status

Active

Licence Category

Registered

Sponsor Information

Sponsor Name

Arrotex Pharmaceuticals Pty Ltd

Sponsor Item Name

Arrotex Pharmaceuticals Pty Ltd.

Active Ingredients

Ingredient Name

risedronate sodium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

APOTEX-RISEDRONATE/Ca 35/1250 risedronate sodium 35 mg tablet and calcium carbonate 1250 mg tablet composite blister pack (184626) - TGA 批准文号 | MedPath

AI-Powered Research

Premium Access

APOTEX-RISEDRONATE/Ca 35/1250 risedronate sodium 35 mg tablet and calcium carbonate 1250 mg tablet composite blister pack (184626)

Sponsor Information

Active Ingredients

MedPath

Product

Company

Legal